Pharmacokinetic Study of Aprepitant in BEP Treatment of Patients With Testis Carcinoma (A-BEP)

Stopped change of study population and chemotherapeutic regimen

Conditions

• Nausea
• Vomiting

Interventions

• DRUG: Aprepitant

Sponsor

Radboud University Medical Center

Collaborators

• [object Object]